Webjet Limited (WEBJF)
USD 0.93
(0.0%)
USD 0.93
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 119.92 Million | 117.92 Million | 53.58 Million | -24.44 Million | -250.8 Million | 32.14 Million |
| Net Income | 47.4 Million | 9.69 Million | -61.06 Million | -159.03 Million | -99.03 Million | 42.31 Million |
| Depreciation & Amortization | 29.67 Million | 45.85 Million | 32.4 Million | 33.91 Million | 25.12 Million | 25.26 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 4.36 Million | 5.08 Million | 7.18 Million | 4.15 Million | 3.03 Million | - |
| Change in working capital | 4.89 Million | 37.5 Million | 77.45 Million | 22.69 Million | 107.52 Million | -38.17 Million |
| Other non-cash items | 92.4 Million | 24.86 Million | 4.78 Million | 123.1 Million | -209.73 Million | 91.43 Million |
| Investing Cash Flow | -50.14 Million | -22.79 Million | -36.29 Million | -10.96 Million | -33.9 Million | -170.03 Million |
| Investments in PPE | -26.99 Million | -22.79 Million | -16.01 Million | -10.96 Million | -30.4 Million | -22.94 Million |
| Acquisitions | - | - | -5.91 Million | - | -5.5 Million | -147.08 Million |
| Investment purchases | -21.71 Million | -32.3 Million | -14.36 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.43 Million | 32.3 Million | -28.66 Million | -13.16 Million | 2 Million | - |
| Financing Cash Flow | 1.17 Million | -55.81 Million | 115.17 Million | 77.61 Million | 292 Million | 157.68 Million |
| Debt repayment | -2.54 Million | -56.28 Million | -148.17 Million | -81.57 Million | -19.1 Million | -63.29 Million |
| Dividends payments | - | - | -9.13 Million | - | -18.3 Million | -25.9 Million |
| Common Stock Repurchased | - | - | -2.46 Million | - | - | - |
| Common Stock Issuance | 3.71 Million | 3.47 Million | 3.44 Million | -1.44 Million | 333.9 Million | 112.56 Million |
| Other Financing Activities | -3.9 Million | -3 Million | 271.51 Million | 103.2 Million | -4.5 Million | - |
| Accounts receivables | -38.99 Million | -59.63 Million | -53.95 Million | 18.43 Million | 107.52 Million | -8.91 Million |
| Accounts payables | 43.88 Million | 97.13 Million | 131.41 Million | 4.26 Million | - | -29.26 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 343.54 Million | 324.57 Million | 198.79 Million | 148.34 Million | 211.4 Million | 140.97 Million |
| Cash at end of period | 410.88 Million | 343.54 Million | 324.57 Million | 198.79 Million | 209.6 Million | 148.34 Million |
| Capital Expenditure | -26.99 Million | -22.79 Million | -16.01 Million | -10.96 Million | -30.4 Million | -22.94 Million |
| Effect of forex changes on cash | 7.4 Million | 21.4 Million | -4.3 Million | -4.05 Million | -9.1 Million | -7.6 Million |
| Net cash flow / Change in cash | 67.34 Million | 18.96 Million | 125.78 Million | 50.44 Million | -1.8 Million | 7.37 Million |
| Free Cash Flow | 92.92 Million | 95.12 Million | 37.56 Million | -35.41 Million | -281.2 Million | 9.19 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.28 Million | 47.4 Million | 8.65 Million | 30.43 Million | 15.75 Million | 9.69 Million |
| Depreciation & Amortization | 7.72 Million | 29.67 Million | 340.78 Thousand | 14.02 Million | 7.25 Million | 45.85 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.2 Million | 4.36 Million | 1.26 Million | 964.25 Thousand | 999.06 Thousand | 5.08 Million |
| Change in working capital | -1.98 Million | 4.89 Million | -2.07 Million | 47.54 Million | -17.88 Million | 37.5 Million |
| Other non-cash items | -10.3 Million | 92.4 Million | -3.03 Million | -2.89 Million | 50.05 Million | 24.86 Million |
| Investing Cash Flow | -8.02 Million | -50.14 Million | -8.38 Million | -33.64 Million | -17.38 Million | -22.79 Million |
| Investments in PPE | -195.61 Thousand | -26.99 Million | -204.47 Thousand | -14.86 Million | -1.29 Million | -22.79 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -4.1 Million | -21.71 Million | - | -17.37 Million | - | -32.3 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -7.82 Million | -1.43 Million | -8.17 Million | -1.41 Million | -16.08 Million | 32.3 Million |
| Financing Cash Flow | 782.47 Thousand | 1.17 Million | 817.88 Thousand | -386.04 Thousand | -199.81 Thousand | -55.81 Million |
| Debt repayment | - | -2.54 Million | - | - | - | -56.28 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.99 Million | 3.71 Million | - | 707.74 Thousand | - | 3.47 Million |
| Other Financing Activities | 782.47 Thousand | -3.9 Million | 817.88 Thousand | -192.85 Thousand | -199.81 Thousand | -3 Million |
| Accounts receivables | -1.98 Million | -38.99 Million | -2.07 Million | -34.55 Million | -17.88 Million | -59.63 Million |
| Accounts payables | -39.32 Million | 43.88 Million | - | 82.09 Million | - | 97.13 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 407.78 Million | 343.54 Million | - | 343.54 Million | - | 324.57 Million |
| Cash at end of period | 410.88 Million | 410.88 Million | -1.26 Million | 407.78 Million | 39.92 Million | 343.54 Million |
| Capital Expenditure | -195.61 Thousand | -26.99 Million | -204.47 Thousand | -14.86 Million | -1.29 Million | -22.79 Million |
| Effect of forex changes on cash | 1.1 Million | 7.4 Million | 1.15 Million | 1.28 Million | 1.33 Million | 21.4 Million |
| Net cash flow / Change in cash | 3.1 Million | 67.34 Million | -1.26 Million | 64.24 Million | 39.92 Million | 18.96 Million |
| Free Cash Flow | 4.72 Million | 92.92 Million | 4.94 Million | 93.74 Million | 54.88 Million | 95.12 Million |
0878
CEE
RCAT
ALINV
ORE
AOT-R